Mulmit

Solid Biosciences Inc.Solid Biosciences Inc.

SLDB Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2022-12-318,094,000-106,452,000—-10.1
2021-12-3113,620,000-72,254,000—-10.14
2020-12-310-88,406,000—-25.5
2019-12-310-119,318,000-117,223,000—
2018-12-310-75,687,000-74,798,000—

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-02SMITH IAN F3,440
2026-07-02SMITH IAN F3,440
2026-06-10Nagendran Sukumar77,500
2026-06-10SMITH IAN F77,500
2026-06-10Ganot Ilan77,500
2026-06-10PERCEPTIVE ADVISORS LLC77,500
2026-06-10Keresty Georgia77,500
2026-06-10Freed Martin I77,500
2026-06-10Kahn Clare77,500
2026-06-10Sullivan Lynne Marie77,500
2026-06-10Stone Adam Leo77,500
2026-04-02SMITH IAN F3,441

8-K events

FiledItems
2026-08-06Other events · Financial statements and exhibits
2026-06-10Submission of matters to a vote
2026-04-10Officer or director change
2026-03-12Regulation FD disclosure · Other events
2026-03-06Entry into a material agreement · Results of operations · Unregistered sales of equity securities · Other events · Financial statements and exhibits
2025-11-03Results of operations · Regulation FD disclosure · Other events · Financial statements and exhibits
2025-06-13Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2025-05-15Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.